Compared side by side
TB-500 vs GHK-Cu: how they differ
The short answer
TB-500 is the 7-amino-acid stretch of thymosin beta-4 that binds actin, the scaffolding repair cells use to move into injured tissue; GHK-Cu is a copper-binding tripeptide found naturally in human plasma that, in cell and animal studies, boosts collagen and speeds wound repair. TB-500 is run for soft-tissue injuries, while GHK-Cu is also widely used in skincare, on the skin as well as by injection. Commonly reported: stubborn soft-tissue injuries loosening up over a few weeks on TB-500, and smoother skin texture and a more even tone after a month or two on GHK-Cu.
Side by side
| Compared | TB-500 | GHK-Cu |
|---|---|---|
| Category | Healing & recovery | Healing & recovery |
| Also known as | Thymosin Beta-4 Fragment, TB4 | Copper Peptide, GHK-Copper, Tripeptide-1 |
| What it is | A fragment of thymosin beta-4, a protein your body uses for cell repair. | A small copper-binding peptide found naturally in your blood and widely used in skincare. |
| How it works | Synthetic fragment of Thymosin Beta-4: Ac-LKKTETQ, the 7-amino-acid stretch (residues 17–23) that binds actin. The whole protein holds actin building blocks back from forming filaments, a reserve cells draw on when they move. In lab and rodent studies the fragment drew blood-vessel cells, sped wound repair in aged mice and strengthened repaired tendons in rats; the anti-inflammatory findings are for the whole protein. Loading phase 2x/week then drop to maintenance. | Tripeptide (glycyl-histidyl-lysine) that binds a copper(II) ion. It occurs naturally in human plasma, and its sequence sits inside type I collagen and the tissue-remodeling protein SPARC. In cell and animal studies, GHK-Cu increased collagen, decorin and glycosaminoglycan production, raised VEGF output by fibroblasts, and damped inflammatory signals such as IL-6. Human evidence is limited to a handful of topical trials, most of them small. |
| Commonly reported | Stubborn soft-tissue injuries loosening up, with range of motion returning over a few weeks. Its own research is a few animal studies; the human trials tested the whole protein. Often paired with BPC-157. | Smoother texture and a more even tone after a month or two. Injected GHK-Cu hasn't been tested in a controlled trial. |
| Studied range | Research range: 1–2.5 mg. Studied in research — not a recommendation. | Research range: 1–2 mg. Studied in research — not a recommendation. |
| How often | 2x/week loading, 1–2mg/week maintenance | Daily |
| Half-life | ~0.5–2 hours (measured for the whole protein, thymosin beta-4, given IV to healthy volunteers; TB-500 itself has never been measured in people) | Not measured in humans (breaks down quickly in plasma in rat and lab studies) |
| Route | SubQ injection, IM injection | SubQ injection, Topical application, IM injection |
| Typical run | Loading phase 2x/week for 4–6 weeks, then maintenance 1x/week or stop. Common to cycle 6–8 weeks on, time off. | Often run 8–12 weeks. Can be cycled or run continuously at lower doses. Community consensus is loose. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Injection site reaction, fatigue, nausea, headache, lethargy | Injection site reaction, skin irritation (topical), mild flushing |
- Category
- TB-500Healing & recovery
- GHK-CuHealing & recovery
- Also known as
- TB-500Thymosin Beta-4 Fragment, TB4
- GHK-CuCopper Peptide, GHK-Copper, Tripeptide-1
- What it is
- TB-500A fragment of thymosin beta-4, a protein your body uses for cell repair.
- GHK-CuA small copper-binding peptide found naturally in your blood and widely used in skincare.
- How it works
- TB-500Synthetic fragment of Thymosin Beta-4: Ac-LKKTETQ, the 7-amino-acid stretch (residues 17–23) that binds actin. The whole protein holds actin building blocks back from forming filaments, a reserve cells draw on when they move. In lab and rodent studies the fragment drew blood-vessel cells, sped wound repair in aged mice and strengthened repaired tendons in rats; the anti-inflammatory findings are for the whole protein. Loading phase 2x/week then drop to maintenance.
- GHK-CuTripeptide (glycyl-histidyl-lysine) that binds a copper(II) ion. It occurs naturally in human plasma, and its sequence sits inside type I collagen and the tissue-remodeling protein SPARC. In cell and animal studies, GHK-Cu increased collagen, decorin and glycosaminoglycan production, raised VEGF output by fibroblasts, and damped inflammatory signals such as IL-6. Human evidence is limited to a handful of topical trials, most of them small.
- Commonly reported
- TB-500Stubborn soft-tissue injuries loosening up, with range of motion returning over a few weeks. Its own research is a few animal studies; the human trials tested the whole protein. Often paired with BPC-157.
- GHK-CuSmoother texture and a more even tone after a month or two. Injected GHK-Cu hasn't been tested in a controlled trial.
- Studied range
- TB-500Research range: 1–2.5 mg. Studied in research — not a recommendation.
- GHK-CuResearch range: 1–2 mg. Studied in research — not a recommendation.
- How often
- TB-5002x/week loading, 1–2mg/week maintenance
- GHK-CuDaily
- Half-life
- TB-500~0.5–2 hours (measured for the whole protein, thymosin beta-4, given IV to healthy volunteers; TB-500 itself has never been measured in people)
- GHK-CuNot measured in humans (breaks down quickly in plasma in rat and lab studies)
- Route
- TB-500SubQ injection, IM injection
- GHK-CuSubQ injection, Topical application, IM injection
- Typical run
- TB-500Loading phase 2x/week for 4–6 weeks, then maintenance 1x/week or stop. Common to cycle 6–8 weeks on, time off.
- GHK-CuOften run 8–12 weeks. Can be cycled or run continuously at lower doses. Community consensus is loose.
- Evidence
- TB-500Emerging: primarily preclinical / limited human data
- GHK-CuEmerging: primarily preclinical / limited human data
- Common side effects
- TB-500Injection site reaction, fatigue, nausea, headache, lethargy
- GHK-CuInjection site reaction, skin irritation (topical), mild flushing
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
TB-500
- Day 1–7 Week one: set your baseline
- Day 7–14 Stiffness often starts to ease
- Day 14–28 Load tolerance often picks up
- Day 28–42 Gains slow, repair keeps going
- Day 42–56 Weeks 6 to 8: how far it's come
GHK-Cu
- Day 1–14 The first two weeks are groundwork
- Day 14–28 Texture tends to move first
- Day 28–56 This is where results tend to show
- Day 56–84 Weeks 8–12: time for an honest look
- Day 84+ Past the studied window — your read now
Together or one or the other
TB-500 and GHK-Cu are a common stack: each lists the other among its common stacks, and they’re together in the GLOW and KLOW stacks.
- GLOW: Skin & soft-tissue repair stack (BPC-157, TB-500 and GHK-Cu).
- KLOW: GLOW plus KPV — four repair peptides in one vial (KPV, BPC-157, TB-500 and GHK-Cu).
Community · GHK-Cu
Why GHK-Cu pairs with healing peptides
GHK-Cu brings the skin and collagen side; BPC-157 and TB-500 bring tendon, gut and wound repair. Together they repair from the surface down, which is the logic behind GLOW. Commonly reported: firmer skin and smoother recovery after procedures and small injuries.
Questions people ask
How long do TB-500 and GHK-Cu last?
The half-life of TB-500 is ~0.5–2 hours (measured for the whole protein, thymosin beta-4, given IV to healthy volunteers; TB-500 itself has never been measured in people). The half-life of GHK-Cu is not measured in humans (breaks down quickly in plasma in rat and lab studies).
How often are TB-500 and GHK-Cu taken?
TB-500: 2x/week loading, 1–2mg/week maintenance. Routes: SubQ injection, IM injection. GHK-Cu: daily. Routes: SubQ injection, topical application, IM injection.
How are TB-500 and GHK-Cu dosed in research?
The research range for TB-500 is 1–2.5 mg. The research range for GHK-Cu is 1–2 mg. Studied in research — not a recommendation.
What are the common side effects of TB-500 and GHK-Cu?
For TB-500, the library lists: injection site reaction, fatigue, nausea, headache, lethargy. For GHK-Cu: injection site reaction, skin irritation (topical), mild flushing.
Are TB-500 and GHK-Cu taken together?
TB-500 and GHK-Cu are a common stack: each lists the other among its common stacks, and they’re together in the GLOW and KLOW stacks. GHK-Cu brings the skin and collagen side; BPC-157 and TB-500 bring tendon, gut and wound repair. Together they repair from the surface down, which is the logic behind GLOW. Commonly reported: firmer skin and smoother recovery after procedures and small injuries.